rewirebio.iobenchmarks
Evidence claim

Baseline: Interpret BRCA1/BRCA2 germline variants

Baseline of Interpret BRCA1/BRCA2 germline variants

BayesDel under the ENIGMA specification

Baseline method for the use case, reviewed against its cited sources.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

18 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Claimed field
baseline
Context-only references
ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML
Retrieved: 2026-10-09T21:18:06Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
baseline
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Method ids
1 values
  • uc-clinical-20260930-method-bayesdel
Context-only references
ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML
Retrieved: 2026-10-09T21:18:06Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.method_ids

Source artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Method ids
1 values
  • uc-clinical-20260930-method-bayesdel
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.method_ids

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Pinned records
3 values
  • record id
    brca-20261009-source-ramadane2025
    fields
    • status
    • attributes.artifact_sha256
    sha256
    e22a0250816d22053fcea9aea187fd3e370deedf30ec9374abc3a0c4c46d3c17
  • record id
    uc-clinical-20260930-source-enigma
    fields
    • status
    • attributes.artifact_sha256
    sha256
    98137d62503a5f20532852f6a20517afeaacd0b0ae8e36dfccc9a48385284528
  • record id
    use-case-brca1-brca2-germline-interpretation
    fields
    • status
    • name
    • description
    • facets
    • attributes.question
    • attributes.decision
    • attributes.inputs
    • attributes.output
    • attributes.exclusions
    • attributes.setting
    • attributes.clinical_scope
    • attributes.intended_users
    sha256
    9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd
Context-only references
ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML
Retrieved: 2026-10-09T21:18:06Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.pins

Source artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Pinned records
3 values
  • record id
    brca-20261009-source-ramadane2025
    fields
    • status
    • attributes.artifact_sha256
    sha256
    e22a0250816d22053fcea9aea187fd3e370deedf30ec9374abc3a0c4c46d3c17
  • record id
    uc-clinical-20260930-source-enigma
    fields
    • status
    • attributes.artifact_sha256
    sha256
    98137d62503a5f20532852f6a20517afeaacd0b0ae8e36dfccc9a48385284528
  • record id
    use-case-brca1-brca2-germline-interpretation
    fields
    • status
    • name
    • description
    • facets
    • attributes.question
    • attributes.decision
    • attributes.inputs
    • attributes.output
    • attributes.exclusions
    • attributes.setting
    • attributes.clinical_scope
    • attributes.intended_users
    sha256
    9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.pins

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Rationale
The ClinGen ENIGMA BRCA1/BRCA2 specification uses BayesDel, with gene-specific cutpoints, as its computational evidence for missense variants (PP3/BP4), so a new predictor is judged against it. BayesDel is a meta-predictor that combines other scores, so it is a simple trained model rather than a pre-machine-learning method; manual review under the specification, the full comparator, has no method record.
Context-only references
ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML
Retrieved: 2026-10-09T21:18:06Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.rationale

Source artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Rationale
The ClinGen ENIGMA BRCA1/BRCA2 specification uses BayesDel, with gene-specific cutpoints, as its computational evidence for missense variants (PP3/BP4), so a new predictor is judged against it. BayesDel is a meta-predictor that combines other scores, so it is a simple trained model rather than a pre-machine-learning method; manual review under the specification, the full comparator, has no method record.
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.rationale

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Source location
uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)
Context-only references
ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML
Retrieved: 2026-10-09T21:18:06Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Source location
uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-baseline-brca1-brca2-germline-interpretation

field
baseline
value
BayesDel under the ENIGMA specification
source locator
uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)
method ids
uc-clinical-20260930-method-bayesdel
rationale
The ClinGen ENIGMA BRCA1/BRCA2 specification uses BayesDel, with gene-specific cutpoints, as its computational evidence for missense variants (PP3/BP4), so a new predictor is judged against it. BayesDel is a meta-predictor that combines other scores, so it is a simple trained model rather than a pre-machine-learning method; manual review under the specification, the full comparator, has no method record.
review
method: source-hash-verification; automated-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the agent that proposed the baseline; no human review claimed; reviewed at: 2026-10-12T18:00:00Z; note: Reviewer corrected rationale. Sources re-retrieved and read; method records and their configuration links checked against the use case's active comparisons. Names the reference newer methods are compared with, not a recommendation. See docs/reviews/use-cases/baselines-2026-10-12.md.
pins
record id: brca-20261009-source-ramadane2025; fields: status; attributes.artifact_sha256; sha256: e22a0250816d22053fcea9aea187fd3e370deedf30ec9374abc3a0c4c46d3c17; record id: uc-clinical-20260930-source-enigma; fields: status; attributes.artifact_sha256; sha256: 98137d62503a5f20532852f6a20517afeaacd0b0ae8e36dfccc9a48385284528; record id: use-case-brca1-brca2-germline-interpretation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd
Related records

Suggest a correction